2024. Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients with Stage I-III Cutaneous Melanoma . SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s386. DOI:https://doi.org/10.25251/skin.8.supp.386.